Echo Therapeutics (ECTE)
(Delayed Data from OTC)
$0.00 USD
0.00 (100.00%)
Updated Sep 2, 2021 03:12 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Echo Therapeutics Inc. [ECTE]
Reports for Purchase
Showing records 1 - 20 ( 30 total )
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
Platinum intends to file lawsuit against Echo - dropping coverage
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
Strategic China partnership and $10 million cash infusion announced
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
Reported impressive Symphony CE Mark study results, raising PT to $9.35
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
Echo reports Q3, CE Mark study results expected in a few weeks
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
Delays, delays, delays - do we hear an Echo? Forthrightness refreshing, however...
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
CEO Mooney on immediate leave of absence, EU approval on track for year-end
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
Releases Q1 results, design freeze achieved, waiting on IRBs
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
New funding should carry Echo through approval - critical care CGM thoughts
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
Reports Q3 2012 results ahead of estimates, gears up for Symphony
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
ECTE Echo reported Q2 2012 results, credit facility announced
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
ECTE Echo announces positive results in second leg of critical care pilot study
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
ECTE Echo at the American Diabetes Association Scientific Sessions
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
ECTE Echo announces inline Q1 2012 results; lowering rating and price target
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
ECTE Echo announces positive results in critical care pilot study
Provider: FELTL & COMPANY
Analyst: HAYNOR B